Frontida BioPharm

Philadelphia,  PA 
United States
  • Booth: 2037

Frontida BioPharm is a US-based CDMO focused on developing and manufacturing immediate/controlled release oral delivery products. We offer unique technology platforms for controlled release Oral Solid Dosages and fixed-dose combinations. Technologies include: AdaptDose™ encapsulation of mini-tablets/granules for customized strengths/delivery rates; Duragran® controlled release/ODT beadlet technology; solvent processing for granulations/coatings; DEA Schedule II – V product development/manufacture; and High Potent Active (HPAI) formulations, with 3BB tablets/capsules annual capacity.

For Technical Support with this webpage, please contact support.